ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 697

Does Erythrocyte Sedimentation Rate Reflect and Discriminate Flare from Infection in Systemic Lupus Erythematosus? Correlation with Clinical and Laboratory Parameters of Disease Activity

Valentin S. Schäfer1, Katharina Weiss2, Andreas Krause2 and Wolfgang A. Schmidt3, 1Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 2Medical Centre for Rheumatology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 3Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Infection, Inflammation, laboratory tests and ultrasonography, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: ESR is applied for monitoring disease activity in SLE. It is known to be influenced by age and infections. We aimed at evaluating how ESR correlates with commonly applied disease activity parameters and how infections influence these results.

Methods: Retrospective analysis of laboratory parameters, clinical activity, infection and serositis in consecutive SLE patients between 2006 and 2015. Based on the treating physician´s judgement on disease activity and presence of infection, patients were separated into four groups: flare, infection, both and neither. ESR was correlated to CRP, ferritin, anti-dsDNA antibodies, C3, serositis and erythrocyturia with proteinuria. For age, ESR, CRP, ferritin and age- and gender-adapted ESR (ESRp), mean values between groups were compared. ESRp was calculated as the percentage of an ESR cut-off considering age and gender.                                                                                                

Results: We identified 203 SLE patients with 371 visits, flare n=147, infection n=48, both n=23 and neither flare nor infection n=153. Correlation coefficients of ESR and other parameters are given in table 1; there was moderate correlation with CRP (r=0.47-0.58) and weak correlation with other parameters (r<0.2). As shown in figure 1, ESR and CRP levels were normal in patients in remission, but did not differ between flare, infection or both. ESRp was higher in patients with flare versus with infection (p=0.01). ESR and CRP lost association to activity in infected patients and, conversely, to infection in patients with flare. ESRp, serositis and anti-dsDNA antibodies were related to disease activity regardless of infections (table 2).

Conclusion: ESR is raised in flares, but also in infected and older patients. CRP levels do not enable discrimination between flare and infection. Both parameters argue against flare and infection when normal. ESRp can help to differentiate between flare, infection or even both.

 

Table 1: Correlation coefficients of ESR with other laboratory and clinical parameters

 

CRP

Ferritin

C3-reduction

Raised anti-dsDNA-antibodies

erythrocyturia

+ proteinuria

Serositis

All visits

(n=371)

0.498*

0.256*

0.165*

0.134*

0.186*

 0.079

Flare only

(n=147)

0.549*

0.268*

0.064

0.101

0.141

 0.094

Infection only

(n=48)

0.468*

0.109

0.172

0.12

0.214

-0.338*

Both

(n=23)

0.575*

0.266

0.037

0.205

0.091

-0.09

Silent

(n=153)

0.556*

0.25

0.032

0.082

0.137

-0.016

(Pearson´s r); significant correlation is marked with *.

 

Table 2: Association of laboratory and clinical parameters with SLE flare and infection

 

ESR

ESRp

CRP

Ferritin

C3-reduction

Raised anti-dsDNA-antibodies

Erythrocyturia

+ Proteinuria

Serositis

 

P-value for the association with disease activity

all visits

(n=371)

<0.001*

<0.001*

0.692

0.405

<0.001*

<0.001*

 0.002*

<0.001*

without infection

(n=300)

<0.001*

<0.001*

<0.001*

0.318

<0.001*

<0.001*

0.01*

<0.001*

with infection

(n=71)

0.186

<0.001*

0.321

0.713

    0.268

<0.001*

–

   0.05*

 

P-value for the association with infections

all visits

(n=371)

<0.001*

0.053

<0.001*

0.797

0.384

0.023*

    0.831

0.474

without activity (n=201)

<0.001*

0.001*

<0.001*

0.642

0.281

     0.068

           1

0.766

with activity (n=170)

0.039

0.052

0.213

0.576

0.255

              1

     0.506

1


Figure 1: 95% confidence interval of mean values of age, ESR, ESRp, CRP, and ferritin in SLE groups

 


Disclosure: V. S. Schäfer, None; K. Weiss, None; A. Krause, None; W. A. Schmidt, None.

To cite this abstract in AMA style:

Schäfer VS, Weiss K, Krause A, Schmidt WA. Does Erythrocyte Sedimentation Rate Reflect and Discriminate Flare from Infection in Systemic Lupus Erythematosus? Correlation with Clinical and Laboratory Parameters of Disease Activity [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/does-erythrocyte-sedimentation-rate-reflect-and-discriminate-flare-from-infection-in-systemic-lupus-erythematosus-correlation-with-clinical-and-laboratory-parameters-of-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-erythrocyte-sedimentation-rate-reflect-and-discriminate-flare-from-infection-in-systemic-lupus-erythematosus-correlation-with-clinical-and-laboratory-parameters-of-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology